AstraZeneca oncology R&D chief Jose Baselga passes away at 61
- Baselga was earlier chief medical officer at Memorial Sloan Kettering
- José Baselga suffered from Creutzfeldt-Jakob disease
- Well wishers took to Twitter to express their shock over the oncologist's passing
AstraZeneca oncology R&D chief, Jose Baselga succumbed to Creutzfeldt-Jakob disease and passed away at the age of 61.
A prominent figure in cancer development, Baselga was earlier the chief medical officer at Memorial Sloan Kettering.
Associated with mad cow disease, Creutzfeldt-Jakob disease is a lethal neurodegenerative which progresses rapidly and is suffered by 1 in every million people, reports ENDPOINTS News.
AstraZeneca CEO Pascal Soriot praised Baselga when he joined the pharmaceutical company calling him an "outstanding scientific leader". The late Barcelona native directed a late-stage alliance on Enhertu which got quick approval and helped the franchise to expand rapidly.
Jose's work at MSK led to a wide range of significant new cancer drugs being developed and had worked with one of the biggest names in oncology.
Many of Jose Baselga colleagues and friends took to Twitter to express their shock over the oncologist's passing and to give condolences.
Baselga was also a recognized breast cancer specialist and has been cited for his efforts around PI3K research, which has more recently inspired further investigation around mTOR and AKT inhibition.